JEPAX
Price
$13.91
Change
-$0.10 (-0.71%)
Updated
Jun 13 closing price
Net Assets
6.35B
SCNUX
Price
$11.23
Change
-$0.09 (-0.80%)
Updated
Jun 13 closing price
Net Assets
189.8M
Interact to see
Advertisement

JEPAX vs SCNUX

Header iconJEPAX vs SCNUX Comparison
Open Charts JEPAX vs SCNUXBanner chart's image
JPMorgan Equity Premium Income A
Price$13.91
Change-$0.10 (-0.71%)
VolumeN/A
Net Assets6.35B
Invesco Income Advantage U.S. Fund I
Price$11.23
Change-$0.09 (-0.80%)
VolumeN/A
Net Assets189.8M
JEPAX vs SCNUX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JEPAX vs. SCNUX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JEPAX is a Buy and SCNUX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JEPAX has more cash in the bank: 6.35B vs. SCNUX (190M). JEPAX pays higher dividends than SCNUX: JEPAX (8.02) vs SCNUX (6.35). JEPAX was incepted earlier than SCNUX: JEPAX (7 years) vs SCNUX (17 years). SCNUX (1.15) is less costly to investors than JEPAX (0.85). JEPAX is a more actively managed with annual turnover of: 176.00 vs. SCNUX (54.00). JEPAX (1000) and SCNUX (1000) have matching initial minimum investment requirements. SCNUX annual gain was more profitable for investors over the last year : 11.00 vs. JEPAX (8.09). JEPAX return over 5 years is better than : 71.16 vs. SCNUX (52.41).
JEPAXSCNUXJEPAX / SCNUX
Total Expense Ratio0.851.1375%
Annual Report Gross Expense Ratio0.851.1574%
Fund Existence7 years17 years-
Gain YTD1.2154.21529%
Front Load5%N/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets6.35B190M3,344%
Annual Yield % from dividends8.026.35126%
Returns for 1 year8.0911.0074%
Returns for 3 years35.6948.9873%
Returns for 5 years71.1652.41136%
Returns for 10 yearsN/A49.79-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTBP2.840.02
+0.71%
GT Biopharma
PKX48.48-0.59
-1.20%
POSCO Holdings
INTT6.83-0.09
-1.30%
inTEST Corp
BOOT157.27-5.88
-3.60%
Boot Barn Holdings
PWP17.64-1.08
-5.77%
Perella Weinberg Partners